Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Bioeng. Biotechnol.

Sec. Biosensors and Biomolecular Electronics

Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1663915

A light-controlled one-tube detection platform combining CRISPR-Cas12a and RPA: An innovative approach for rapid diagnosis of Acinetobacter baumannii

Provisionally accepted
Lina  LiangLina Liang*Zihan  ZhouZihan ZhouLele  PanLele PanShihua  LuoShihua LuoJiangmei  MaJiangmei MaBaoyan  RenBaoyan RenXuebin  LiXuebin Li*Guijiang  WeiGuijiang Wei*
  • Youjiang Medical University for Nationalities, Baise, China

The final, formatted version of the article will be published soon.

Acinetobacter baumannii (A. baumannii) is a significant pathogen associated with nosocomial infections, predominantly affecting immunocompromised patients, and is linked to high mortality rates. To control infection rates, there is an urgent need for a diagnostic method that is cost-effective, rapid, and user-friendly, meeting the current demand for timely diagnosis. We have developed a one-tube detection method for UV light unlocking based on RPA-CRISPR/Cas12a technology. This method utilizes the photodegradable chemical group NPOM-dt to chemically modify the crRNA base, preventing it from complementary pairing with the base of the target molecule, thereby temporarily silencing the CRISPR system. After RPA preamplification, the caged modification group on the crRNA was removed with brief irradiation with ultraviolet light to restore the activity of the CRISPR/Cas12a system. This light-controlled one-tube system simplifies operation while significantly reducing the risk of contamination caused by repeated tube openings. Our results demonstrated that the detection platform achieved a limit of detection as low as 10 copies/ÎĽL for target fragments, with no cross-reactivity observed with genomic DNA from six clinically common pathogenic bacteria, showcasing excellent sensitivity and specificity.Additionally, clinical validation was performed using 38 sputum samples. The system successfully identified A. baumannii in sputum specimens, with results consistent with those obtained via conventional PCR. These findings highlight the potential of the light-controlled one-tube RPA-CRISPR/Cas12a system as a promising diagnostic tool.

Keywords: CRISPR/Cas12a, NPOM-dt, One-tube detection, POCT, Acinetobacter baumannii

Received: 11 Jul 2025; Accepted: 29 Jul 2025.

Copyright: © 2025 Liang, Zhou, Pan, Luo, Ma, Ren, Li and Wei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Lina Liang, Youjiang Medical University for Nationalities, Baise, China
Xuebin Li, Youjiang Medical University for Nationalities, Baise, China
Guijiang Wei, Youjiang Medical University for Nationalities, Baise, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.